Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 2,707,191 | 3,307,191 | +600,000 | $50.43M | $130.14M | 11.71% | +$79.70M |
| Cogent Biosciences, Inc.(COGT) | 6,225,641 | 9,003,418 | +2,777,777 | $44.70M | $129.29M | 11.63% | +$84.59M |
| Axsome Therapeutics, Inc.(AXSM) | 815,176 | 815,176 | 0 | $85.10M | $99.00M | 8.91% | +$13.91M |
| Apogee Therapeutics Inc | 2,048,647 | 2,048,647 | 0 | $88.97M | $81.39M | 7.32% | -$7.58M |
| Enliven Therapeutics Inc | 3,711,444 | 3,711,444 | 0 | $74.45M | $75.97M | 6.84% | +$1.52M |
| Viridian Therapeutics, Inc.(VRDN) | 3,459,913 | 3,459,913 | 0 | $48.37M | $74.66M | 6.72% | +$26.30M |
| Oruka Therapeutics, Inc.(ORKA) | 3,371,922 | 3,705,262 | +333,340 | $37.80M | $71.25M | 6.41% | +$33.45M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 1,772,839 | 1,772,839 | 0 | $49.05M | $68.84M | 6.19% | +$19.78M |
| Scholar Rock Holding Corporation(SRRK) | 1,824,031 | 1,824,031 | 0 | $64.61M | $67.93M | 6.11% | +$3.32M |
| Spyre Therapeutics, Inc.(SYRE) | 4,018,101 | 4,018,101 | 0 | $60.15M | $67.34M | 6.06% | +$7.19M |
| Nuvalent Inc | 727,563 | 727,563 | 0 | $55.51M | $62.92M | 5.66% | +$7.41M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 713,434 | +713,434 | $0 | $60.57M | 5.45% | +$60.57M |
| Zenas BioPharma, Inc.(ZBIO) | 1,892,806 | 1,892,806 | 0 | $18.34M | $42.02M | 3.78% | +$23.68M |
| Jade Biosciences Inc | 3,220,368 | 3,220,368 | 0 | $32.17M | $27.79M | 2.50% | -$4.38M |
| Astria Therapeutics Inc | 3,554,129 | 3,554,129 | 0 | $19.05M | $25.87M | 2.33% | +$6.82M |
| Crescent Biopharma, Inc.(CBIO) | 1,387,866 | 1,387,866 | 0 | $22.40M | $16.50M | 1.48% | -$5.90M |
| Inhibikase Therapeutics, Inc.(IKT) | 6,125,000 | 6,125,000 | 0 | $11.94M | $9.92M | 0.89% | -$2.02M |
| CytomX Therapeutics, Inc.(CTMX) | 3,896,582 | 0 | -3,896,582 | $8.85M | $0 | — | -$8.85M |